Group 1: Verteporfin PDT + sham injection
-PDT given on Day 0 then PRN q3monthly
Group 2: Sham PDT + Intravitreal Ranibizumab 0.3mg monthly
Group 3: Sham PDT + Intravitreal Ranibizumab 0.5mg monthly
Outcomes
PDT
RAN
Lost < 15 letters from baseline
65.7%
89.9-90.0%
Gained ≥ 15 letters
6.3%
34.0-41.0%
VA change (letters)
-9.8
+8.1 to 10.7
Share This Article :
Please provide feedback on content published. Thank you.
Source Archive